Literature DB >> 49797

Serum-phenytoin levels in management of epilepsy.

A Richens, A Dunlop.   

Abstract

Steady-state serum-phenytoin levels were measured in five patients whose phenytoin dosage was changed three or more times for therapeutic purposes. Data from four of these patients and from fifteen others have been used to construct a nomogram which permits the clinician, given a single, accurate, steady-state phenytoin level, to adjust the dosage to achieve the desirable therapeutic concentration of 60 or 80 mumol per litre (15 or 20 mug. per ml.).

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 49797     DOI: 10.1016/s0140-6736(75)90962-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  49 in total

Review 1.  ABC of monitoring drug therapy. Phenytoin.

Authors:  J K Aronson; M Hardman; D J Reynolds
Journal:  BMJ       Date:  1992-11-14

2.  Classical Michaelis-Menten and system theory approach to modeling metabolite formation kinetics.

Authors:  Jovan Popović
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2004 Jul-Sep       Impact factor: 2.441

Review 3.  Bayesian parameter estimation and population pharmacokinetics.

Authors:  A H Thomson; B Whiting
Journal:  Clin Pharmacokinet       Date:  1992-06       Impact factor: 6.447

4.  Shortcut formulae for pharmacokinetic dosage adjustments.

Authors:  Robert J Belloto
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

5.  Detection and prevention of prescriptions with excessive doses in electronic prescribing systems.

Authors:  H M Seidling; A Al Barmawi; J Kaltschmidt; T Bertsche; M G Pruszydlo; W E Haefeli
Journal:  Eur J Clin Pharmacol       Date:  2007-09-05       Impact factor: 2.953

6.  Dose-dependence of the pharmacokinetics of quinidine.

Authors:  P Bolme; U Otto
Journal:  Eur J Clin Pharmacol       Date:  1977-08-17       Impact factor: 2.953

7.  Evaluation of a bayesian pharmacokinetic program for phenytoin concentration predictions in outpatient population.

Authors:  J M Gaulier; R Boulieu; C Fischer
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Apr-Jun       Impact factor: 2.441

8.  Letter: Antipyrine half life and clearance in clinical practice.

Authors:  B Whitling; M Ullah; P A Meredith
Journal:  Br Med J       Date:  1976-08-21

Review 9.  Clinical pharmacokinetics and pharmacological effects of carbamazepine and carbamazepine-10,11-epoxide. An update.

Authors:  L Bertilsson; T Tomson
Journal:  Clin Pharmacokinet       Date:  1986 May-Jun       Impact factor: 6.447

Review 10.  Computer assisted prescribing of drugs.

Authors:  G E Mawer
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.